Open AccessMulticenter study of the clinicopathological features and recurrence risk prediction model of early-stage breast cancer with low-positive human epidermal growth factor receptor 2 expression in China (Chinese Society of Breast Surgery 021)
Author(s) -
Ling Xin,
Qian Wu,
Chongming Zhan,
Hongyan Qin,
Hongyu Xiang,
Ling Xu,
Jingming Ye,
Xuening Duan,
Yinhua Liu
Publication year - 2022
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000002056
Subject(s) - medicine , breast cancer , stage (stratigraphy) , proportional hazards model , oncology , cancer , pathological , metastasis , multivariate analysis , paleontology , biology
: Breast cancer with low-positive human epidermal growth factor receptor 2 (HER2) expression has triggered further refinement of evaluation criteria for HER2 expression. We studied the clinicopathological features of early-stage breast cancer with low-positive HER2 expression in China and analyzed prognostic factors.